These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26037731)

  • 21. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial of genotype-based Coumadin initiation.
    Burmester JK; Berg RL; Yale SH; Rottscheit CM; Glurich IE; Schmelzer JR; Caldwell MD
    Genet Med; 2011 Jun; 13(6):509-18. PubMed ID: 21423021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithms.
    Hamberg AK; Friberg LE; Hanséus K; Ekman-Joelsson BM; Sunnegårdh J; Jonzon A; Lundell B; Jonsson EN; Wadelius M
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1275-83. PubMed ID: 23307232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
    Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
    Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.
    Kimmel SE; French B; Anderson JL; Gage BF; Johnson JA; Rosenberg YD; Geller NL; Kasner SE; Eby CS; Joo J; Caldwell MD; Goldhaber SZ; Hart RG; Cifelli D; Madigan R; Brensinger CM; Goldberg S; Califf RM; Ellenberg JH
    Am Heart J; 2013 Sep; 166(3):435-41. PubMed ID: 24016491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery.
    Katada Y; Nakagawa S; Minakata K; Odaka M; Taue H; Sato Y; Yonezawa A; Kayano Y; Yano I; Nakatsu T; Sakamoto K; Uehara K; Sakaguchi H; Yamazaki K; Minatoya K; Sakata R; Matsubara K
    J Clin Pharm Ther; 2017 Oct; 42(5):591-597. PubMed ID: 28503837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.
    Kim YK; Nieuwlaat R; Connolly SJ; Schulman S; Meijer K; Raju N; Kaatz S; Eikelboom JW
    J Thromb Haemost; 2010 Jan; 8(1):101-6. PubMed ID: 19840361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.
    Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA
    Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin initiation nomograms for venous thromboembolism.
    Garcia P; Ruiz W; Loza Munarriz C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD007699. PubMed ID: 23839808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
    Stergiopoulos K; Brown DL
    JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials.
    Wang F; Guo J; Zhang A
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):127-135. PubMed ID: 30688796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study.
    Jorgensen AL; Prince C; Fitzgerald G; Hanson A; Downing J; Reynolds J; Zhang JE; Alfirevic A; Pirmohamed M
    BMC Med; 2019 Apr; 17(1):76. PubMed ID: 30961588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the impact of body mass index on warfarin requirements in hospitalized patients.
    Tellor KB; Nguyen SN; Bultas AC; Armbruster AL; Greenwald NA; Yancey AM
    Ther Adv Cardiovasc Dis; 2018 Aug; 12(8):207-216. PubMed ID: 29914293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.